Literature DB >> 462918

Improved yields of factor VIII from heparinized plasma.

G A Rock, W H Cruickshank, E S Tackaberry, D S Palmer.   

Abstract

The Factor VIII procoagulant activity in plasma, cryoprecipitate, and their polyethylene glycol (PEG) precipitates is markedly increased if blood is collected into heparin rather than into citrate phosphate dextrose (CPD). There is a 34% increase in the initial level of the Factor VIII activity in the heparinized plasma with 78% of this initial activity (184 U) recovered in the cryoprecipitated. As well, the stability of the Factor VIII activity is improved: after 24 h of incubation at 22 degrees C, 99% of the initial activity is retained in heparinized plasma whereas only 64% remains in CPD plasma. The cryoprecipitate prepared from heparinized plasma is equally stable after 24 h. The PEG concentrate prepared from the cryoprecipitate of heparinized plasma is increased to 128 U compared to only 54 U from CPD plasma. Relative recoveries were 531 U/l for heparinized plasma versus 215 U/l for CPD plasma. This represents a 147% increase in yield.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 462918     DOI: 10.1111/j.1423-0410.1979.tb04437.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  4 in total

1.  Novel cryoprecipitate for wound healing and skin grafts in rats.

Authors:  Thomas Scholz; Joshua Waltzman; Garrett A Wirth; Senait W Dyson; William J Owens; Edward Shanbrom; Gregory R D Evans
Journal:  Int Wound J       Date:  2008-10       Impact factor: 3.315

2.  The use of blood components in surgical transfusion therapy.

Authors:  C F Högman; L Bagge; L Thorén
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

3.  Enhanced cryoprecipitate for skin graft and donor site wound healing in pigs.

Authors:  Thomas Sebastian Vetter; Donald S Mowlds; Thomas Scholz; Su Bong Nam; Fritz Lin; John W Owens; Dilip Dey; Garrett A Wirth; Gregory R D Evans
Journal:  Int Wound J       Date:  2012-08-21       Impact factor: 3.315

4.  Clotting factor VIII (FVIII) and thrombin generation in camel plasma: A comparative study with humans.

Authors:  Abdel Galil M Abdel Gader; Abdul Karim M Al Momen; Abdulqader Alhaider; Marjory B Brooks; James L Catalfamo; Ahmed A Al Haidary; Mansour F Hussain
Journal:  Can J Vet Res       Date:  2013-04       Impact factor: 1.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.